Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000029

CEO bought 255,000 shares at an average $0.01 ($2,859)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

21 lines
Date Transaction Shares Price Value Owned after D/I
2019-05-02 Purchase : show line 1 in the form +33,737 $0.01 $371 21,370,860 D
2019-05-02 Purchase : show line 2 in the form +66,263 $0.01 $762 21,437,123 D
2019-05-02 Purchase : show line 3 in the form +5,000 $0.01 $57 21,442,123 D
2019-05-02 Purchase : show line 4 in the form +3,200 $0.01 $35 21,445,323 D
2019-05-02 Purchase : show line 5 in the form +24,800 $0.01 $273 21,470,123 D
2019-05-02 Purchase : show line 6 in the form +10,000 $0.01 $109 21,480,123 D
2019-05-02 Purchase : show line 7 in the form +18,000 $0.01 $198 21,498,123 D
2019-05-02 Purchase : show line 8 in the form +2,000 $0.01 $22 21,500,123 D
Open-market purchases · 255,000 sh · avg $0.01 · $2,859
Loading xslF345X03/primary_doc.xml…